Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_cdb3a6234fe13190b5cd8adb96ecec0a http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_294399d090767befce04036a3e4f7c10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d2b177405b5abd3ad98a95977d81778c http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_98510a9ad48bc9b98e49491b39c425bc |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01K2217-05 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-4703 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-68 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-09 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-47 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-40 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H21-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A01K67-027 |
filingDate |
1998-04-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cd564dc5bff7d05702fa7e6a116aa737 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2fffb48ae3168c16d2fdb71385802d6d http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0c58035cfaf4c988316f13d3d2fb6fe8 |
publicationDate |
1998-10-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
WO-9848010-A1 |
titleOfInvention |
Novel human tumour suppressor gene |
abstract |
A novel human progestin-regulated gene designated EDD (E3 isolated by Differential Display) is disclosed which encodes a product exhibiting significant amino acid sequence identity with the HYD protein (hyperplastic discs) from Drosophila melanogaster and the 100 kDa HECT (homologous to E6-AP carboxyl terminus) domain protein from rat. The EDD gene appears to represent a tumour suppressor gene and the detection of a polymorphism or alteration in the gene from a subject may be useful for the diagnosis or determination of a predisposition to hyperproliferative disease such as a cancer. An assay for assessing progestin-responsiveness in a subject is also disclosed. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2004022778-A1 |
priorityDate |
1997-04-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |